Interestingly, no significant relationship was observed between alpha diversity and these clinical characteristics (see Fig. S2a through e in the supplemental material); however, beta diversity was found to be significantly associated with WHO grade of glioma and Ki-67 expression (see Fig. S2f and g). The gene discussed is MKI67; the disease is central nervous system cancer.